Skip to content

MolDrug AI Systems works in the field of computational chemistry, molecular modeling, and in general in technologies for computational optimization of chemical compound properties


Slide 2

2020-2021 | Moldrug

Image is not available

Computational and experimental research for the identification of new antineoplastic inhibitors of kinase dimerization.

Slide 4
Image is not available

Modeling the pharmacokinetics profiles of therapeutic peptides by chemoinformatics methods. PEPTIMOL.

Slide 5

2020-2022 | Moldrug

Image is not available

Research of computational models for the determination of pharmacokinetical parameters and implementation in a technological platform. PTQ2018- 010262.

Slide 6

2020-2022 | Moldrug

Image is not available

The MetaQSAR project consists in the development of a computational platform that enables the automatic generation of QSAR models for the prediction of any molecular property of interest, with a minimal intervention of the user.

Slide 8

2021-2023 | Moldrug

Image is not available

Identifying new anti-cancer drugs by computational multi-target approaches targeting the G-quadruplex DNA.

Slide 1

2021 | Moldrug

Image is not available

Implementation of essential elements for a simpler remote working in the company MOLDRUG AI SYSTEMS S.L.

Slide 3

2019 | Moldrug

Image is not available

Funding, conferred by the Instituto Valenciano de Economía y Competitividad (IVACE), for the preparation, development and preparation of proposals for the Horizon 2020 program.

Slide 7

2020 | Moldrug

Image is not available

With the help of these funds and the support the Programa Xpande Digit@l, the company has started an Internationalization Plan in 2020, with the purpose of improving its competitive positioning abroad.

previous arrowprevious arrow
next arrownext arrow